Cytomegalovirus infection in patients with lymphoma: An important cause of morbidity and mortality

Clinical Lymphoma and Myeloma

Volumn 6, Issue 5, 2006, Pages 393-398

  Torres, Harrys A ^a   Kontoyiannis, Dimitrios P ^a   Aguilera, Elizabeth A ^a   Younes, Anas ^a   Luna, Mario A ^a   Tarrand, Jeffrey J ^a   Nogueras, Graciela M ^b   Raad, Issam I ^a   Chemaly, Roy F ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b U54 Puerto Rico Cancer Center   (Puerto Rico)

Author keywords

Antigenemia; Antiviral toxicity; Pneumonia; Viral infection

Indexed keywords

ALEMTUZUMAB; ANTIVIRUS AGENT; BACTERIAL ANTIGEN; BLOOD GROUP ANTIGEN; CLADRIBINE; CORTICOSTEROID DERIVATIVE; CYTOMEGALOVIRUS ANTIGEN PP65; FLUDARABINE; FOSCARNET; GANCICLOVIR; IMMUNOGLOBULIN; PENTOSTATIN; RITUXIMAB; VALGANCICLOVIR;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; ARTIFICIAL VENTILATION; BONE MARROW SUPPRESSION; CANCER CENTER; CANCER STAGING; COMORBIDITY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE ACTIVITY; DRUG DOSE REGIMEN; DRUG SUBSTITUTION; DRUG TOXICITY; FEMALE; HODGKIN DISEASE; HUMAN; INTENSIVE CARE UNIT; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIVARIATE ANALYSIS; NONHODGKIN LYMPHOMA; PREDICTOR VARIABLE; RELAPSE; RISK FACTOR; TREATMENT OUTCOME; UNITED STATES; UNIVARIATE ANALYSIS; VIROLOGY; VIRUS LOAD;

EID: 33646586095     PISSN: 15579190     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLM.2006.n.016     Document Type: Article

References (32)

1. Salomon N, Perlman DC. Cytomegalovirus pneumonia. Sentin Respir Infect 1999; 14:353-358.
2. de la Hoz RE, Stephens G, Sherlock C. Diagnosis and treatment approaches of CMV infections in adult patients. J Clin Virol 2002; 25(suppl 2):S1-S12.
3. Konoplev S, Champlin RE, Giralt S, et al. Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients. Bone Marrow Transplant 2001; 27:877-881.
4. Nguyen Q, Esrey E, Raad I, et al. Cyromegalovirus pneumonia in adults with leukemia: an emerging problem. Clin Infect Dis 2001; 32:539-545.
5. Nguyen Q, Champlin R, Giralt S, et al. Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipients. Clin Infect Dis 1999; 28:618-623.
6. Ljungman P. Cytomegalovirus pneumonia: presentation, diagnosis, and treatment. Semin Respir Infect 1995; 10:209-215.
7. Crumpacker C, Marlowe S, Zhang JL, et al. Treatment of cytomegalovirus pneumonia. Rev Infect Dis 1988; 10(suppl 3):S538-S546.
8. Manna A, Cordani S, Canessa P, et al. CMV infection and pneumonia in hematological malignancies. J Infect Chemother 2003; 9:265-267.
9. Mera JR, Whimbey E, Elting L, et al. Cytomegalovirus pneumonia in adult nontransplantation patients with cancer: review of 20 cases occurring from 1964 through 1990. Clin Infect Dis 1996; 22:1046-1050.
10. Rosen P, Hajdu S. Cytomegalovirus inclusion disease at autopsy of patients with cancer. Am J Clin Pathol 1971; 55:749-756.
11. Ballotta MR, Borghi L, Borin P. An unusual case of cytomegalovirus infection. Pathologica 1995; 87:682-684.
12. Casazza AR, Duvall CP, Carbone PP. Infection in lymphoma. Histology, treatment, and duration in relation to incidence and survivaL JAMA 1966; 197:710-716.
13. Casazza AR, Duvall CP. Carbone PP. Summary of infectious complications occurring in patients with Hodgkin's disease. Cancer Res 1966; 26:1290-1296.
14. Duvall CP, Casazza AR, Grimley PM, et al. Recovery of cytomegalovirus from adults with neoplastic disease. Ann Intern Med 1966; 64:531-541.
15. Ferrajoli A, O'Brien SM, Cortes JE, et al. Phase II study of alemtuzumab in chronic lymphoproliferative disorders. Cancer 2003; 98:773-778.
16. Chawla. R, Venkatesh P, Garg SP, et al. Cytomegalovirus retinitis in a patient with non-Hodgkin's lymphoma: a diagnostic dilemma. Eur J Ophthalmol 2005; 15:153-157.
17. Monno R, Rendina M, Ceci G, et al. Campylobacter fetus bacteremia in an immunocompromised patient: case report and review of the literature. New Microbiol 2004; 27:281-285.
18. Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002; 34:1094-1097.
19. Cheson BD, Homing SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999; 17:1244.
20. Lister TA, Crowther D, Sutcliffe SB, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol 1989; 7:1630-1636.
21. Chemaly RF, Torres HA, Hachem RY, et al. Cytomegalovirus pneumonia in patients with lymphoma. Cancer 2005; 104:1213-1220.
22. Starr SE, Allison AC. Role of T lymphocytes in recovery from murine cytomegalovirus infection. Infect Immun 1977; 17:45 8-462.
23. Slivnick DJ, Ellis TM, Nawrocki JF, et al. The impact of Hodgkin's disease on the immune system. Semin Oncol 1990; 17:673-682.
24. Aisenberg AC. Manifestations of immunologic unresponsiveness in Hodgkin's disease. Cancer Res 1966; 26:1152-1164.
25. Levy R, Kaplan HS. Impaired lymphocyte function in untreated Hodgkin's disease. N Engl J Med 1974; 290:181-186.
26. ten Napel CH, van Egten-Bijker J, Halie MR, et al. Cytomegalovirus-specific immune response and the cellular immune status of malignant lymphoma. J Clin Lab Immunol 1980; 4:145-151.
27. Wood GS, Edinger A, Hoppe RT, et al. Mycosis fungoides skin lesions contain CD8+ tumor-infiltrating lymphocytes expressing an activated, MHC-restricted cytotoxic T-lymphocyte phenotype. J Cutan Pathol 1994; 21:151-156.
28. Jones SE, Griffith K, Dombrowski P, et al. Immunodeficiency in patients with non-Hodgkin lymphomas. Blood 1977; 49:335-344.
29. Nguyen DD, Cao TM, Dugan K, et al. Cytomegalovirus viremia during Campath-1H therapy for relapsed and refractory chronic lymphocytic leukemia and prolymphocytic leukemia. Clin Lymphoma 2002; 3:105-110.
30. Ikewaki J, Ohtsuka E. Kawano R, et al. Real-time PCR assay compared to nested PCR and antigenemia assays fbr detecting cytomegalovirus reactivation in adult T-cell leukemia-lymphoma patiems. J Clin Microbiol 2003; 41:4382-4387.
31. Erice A, Tierney C, Hirsch M, et al. Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS Clinical Trials Group protocol 360). Clin Infect Dis 2003; 37:567-578.
32. Meyers JD, Ljungman P. Fisher LD. Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation: importance of cytomegalovirus viremia. J Infect Dis 1990; 162:373-380.